# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
Goldman Sachs analyst David Roman initiates coverage on Edwards Lifesciences (NYSE:EW) with a Buy rating and announces Price...
Citigroup analyst Joanne Wuensch upgrades Edwards Lifesciences (NYSE:EW) from Neutral to Buy and raises the price target fro...
Edwards Lifesciences faces EU antitrust complaint from Meril over patent disputes, intensifying regulatory scrutiny. Recent act...
Deutsche Bank analyst Pito Chickering upgrades Edwards Lifesciences (NYSE:EW) from Hold to Buy and raises the price target f...